NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 289 filers reported holding NEOGENOMICS INC in Q2 2020. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27,269 | -9.7% | 2,217 | +18.0% | 0.00% | 0.0% |
| Q2 2023 | $30,196 | -28.3% | 1,879 | -21.5% | 0.00% | -42.9% |
| Q1 2023 | $42,141 | -84.2% | 2,393 | -91.7% | 0.01% | -86.5% |
| Q4 2022 | $267,073 | +44.4% | 28,904 | +34.7% | 0.05% | +33.3% |
| Q3 2022 | $185,000 | +1.1% | 21,454 | -4.2% | 0.04% | 0.0% |
| Q2 2022 | $183,000 | -35.6% | 22,405 | +2.2% | 0.04% | -25.0% |
| Q1 2022 | $284,000 | -30.7% | 21,919 | +20.0% | 0.05% | -22.4% |
| Q4 2021 | $410,000 | -41.0% | 18,270 | +14.0% | 0.07% | -46.4% |
| Q3 2021 | $695,000 | 0.0% | 16,029 | 0.0% | 0.12% | 0.0% |
| Q2 2021 | $695,000 | -4.7% | 16,029 | +6.1% | 0.12% | -13.2% |
| Q1 2021 | $729,000 | -5.7% | 15,111 | +5.3% | 0.14% | -10.0% |
| Q4 2020 | $773,000 | +48.9% | 14,355 | +9.3% | 0.16% | +11.1% |
| Q3 2020 | $519,000 | -68.2% | 13,128 | -75.9% | 0.14% | +105.7% |
| Q1 2020 | $1,634,000 | – | 54,472 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 1,291,019 | $22,477 | 12.11% |
| Greenhouse Funds LLLP | 2,930,014 | $51,011,544 | 4.27% |
| First Light Asset Management, LLC | 2,698,958 | $46,988,859 | 4.23% |
| PERKINS CAPITAL MANAGEMENT INC | 197,000 | $3,430 | 3.23% |
| Altium Capital Management LP | 240,000 | $4,178,400 | 2.32% |
| FORMULA GROWTH LTD | 280,690 | $4,886,813 | 1.57% |
| BOULDER HILL CAPITAL MANAGEMENT LP | 101,065 | $1,759,542 | 1.42% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,374,783 | $23,934,972 | 1.41% |
| EMERALD ADVISERS, LLC | 1,669,324 | $29,062,931 | 1.39% |
| Lisanti Capital Growth, LLC | 528,235 | $9,196,571 | 1.28% |